Journal article icon

Journal article

Improved delivery of the anticancer agent citral using BSA nanoparticles and polymeric wafers.

Abstract:

Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children, with a 5-year survival rate of between 30 and 65%. Standard treatment involves surgery, radiation treatment, and chemotherapy. However, there is a high recurrence rate, particularly from locoregional spread. We investigated the use of the natural compound citral (3,7-dimethyl-2,6-octadienal), which can be found in a number of plants, but is particularly abundant in lemon grass (Cymbopogon citratus) oil, for activity ag...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.2147/nsa.s148068

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Obstetrics & Gynaecology
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Women's and Reproductive Health
Role:
Author
Williams Fund More from this funder
Publisher:
Dove Press Publisher's website
Journal:
Nanotechnology, Science and Applications Journal website
Volume:
10
Pages:
163-175
Publication date:
2017-12-06
Acceptance date:
2017-09-20
DOI:
EISSN:
1177-8903
ISSN:
1177-8903
Pmid:
29263655
Source identifiers:
813038
Language:
English
Keywords:
Pubs id:
pubs:813038
UUID:
uuid:3c3f989b-63db-4e35-b3bb-31962c4ce339
Local pid:
pubs:813038
Deposit date:
2018-01-11

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP